Draft amendments to Medical Devices Rules to ease compliance

The Medical Devices Rules amendments: what happened?

Medical devices range from a pulse oximeter to a knee implant. Many small makers do not have their own sterilisation plant, so they send products to another licensed facility. Until now, that needed a separate “loan licence”, which meant extra paperwork and delay. The Ministry has now removed that layer and widened the list of trusted foreign regulators.

• Rule 44 was amended after wide stakeholder consultation.
• A manufacturer that outsources sterilisation to a facility holding a valid licence under the Rules no longer needs a separate loan licence.
• A traceability mechanism for outsourced sterilisation is kept, with a new labelling requirement.
• Manufacturers get a six-month transition to change labels and packaging.
• Rule 63 now lists the European Union among recognised stringent regulatory jurisdictions.

How are medical devices classified in India?

• The Medical Devices Rules, 2017 place devices in four risk-based classes: A, B, C and D, with Class D the highest risk.
• Class B (low to moderate risk) includes blood pressure monitors, hypodermic needles and pulse oximeters.
• Class C and D (high risk) include cardiac stents and hip and knee implants.

What is a loan licence?

• A licence that lets a firm use another licensed facility for part of its manufacturing.
• Before this change, outsourcing sterilisation needed such a separate licence, duplicating approvals.
• The change cuts duplication, administrative burden, costs and timelines, especially for firms without in-house sterilisation.

What does the Rule 63 change mean?

• For a device without a predicate device, a clinical investigation can be waived if it is approved in a recognised stringent jurisdiction.
• The list was the United States, United Kingdom, Australia, Canada and Japan; the EU is now added.
• EU-approved devices can reach Indian patients faster, with less regulatory burden for importers and makers.

Which constitutional provisions apply?

• Seventh Schedule, List III (Concurrent List), Entry 19: Drugs and poisons, subject to the provisions of entry 59 of List I with respect to opium.
• Article 47: the State shall regard the raising of the level of nutrition and the standard of living of its people and the improvement of public health as among its primary duties.

What has changed in 2026?

How does outsourced sterilisation work now?

1. Maker produces the device
2. Sends it to a sterilisation facility licensed under the Rules
3. No separate loan licence is needed
4. New labelling keeps the device traceable
5. Device reaches the market faster

Why does the Medical Devices Rules amendments matter?

What are the challenges in the Medical Devices Rules amendments?

• Relying on foreign approvals must not weaken India’s own safety checks.
• Traceability of outsourced sterilisation depends on proper labelling and enforcement.
• Small firms need time and guidance to update labels and packaging within six months.
• High-risk devices such as implants need close post-market watch.

What should be done next on the Medical Devices Rules amendments?

• Enforce the new labelling rule well at the end of the transition.
• Finalise the proposed shorter licensing timelines for Class B, C and D devices.
• Strengthen CDSCO’s capacity for audits and post-market surveillance.
• Keep reviewing which foreign jurisdictions qualify as stringent.

What can Prelims ask on the Medical Devices Rules amendments?

• Medical Devices Rules, 2017: four risk classes A to D; Class D is the highest risk.
• Rule 44 (2026): no separate loan licence for outsourced sterilisation at a licensed facility.
• Rule 63 (2026): EU added to US, UK, Australia, Canada, Japan for clinical investigation waiver.
• Drugs and poisons: List III, Entry 19.

How to write about the Medical Devices Rules amendments in Mains

Practice question (10 marks, 150 words): Regulatory simplification in the medical device sector must balance ease of doing business with patient safety. Discuss in the light of the 2026 amendments to the Medical Devices Rules.

• Intro: Medical Devices Rules, 2017; risk-based classes.
• Changes: Rule 44 loan licence removed; Rule 63 EU added.
• Gains: lower cost, faster access, convergence.
• Safeguards: traceability labels, CDSCO oversight.
• Conclusion: Art 47 duty on public health.